Dr. Reddy's Laboratories Limited American Depositary Shares RDY
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market dataready · fetched 2026-11-13T18:53:36.807Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T18:53:06.231837687Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-13T18:52:18.380742+00:00
Dr. Reddy's Laboratories Limited American Depositary Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 10.01 | 474.3% | 41.7% | |||
| 25Δ | 11.82 | 355.9% | 29.5% | |||
| 30Δ | 12.90 | 289.6% | 22.4% | |||
| 35Δ | 20.96 | 363.5% | 50.1% | 13.53 | 253.9% | 18.4% |
| 40Δ | 17.92 | 284.6% | 29.7% | 14.16 | 218.2% | 14.4% |
| 45Δ | 14.79 | 182.5% | 10.3% | |||
| 50Δ | ||||||
| 55Δ | ||||||
| 60Δ | ||||||
| 65Δ | ||||||
| 70Δ | ||||||
| 75Δ | ||||||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 10.01
- IV
- 474.3%
- B/E move
- 41.7%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 11.82
- IV
- 355.9%
- B/E move
- 29.5%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 12.90
- IV
- 289.6%
- B/E move
- 22.4%
35Δ
- Pseudo strike
- 20.96
- IV
- 363.5%
- B/E move
- 50.1%
- Pseudo strike
- 13.53
- IV
- 253.9%
- B/E move
- 18.4%
40Δ
- Pseudo strike
- 17.92
- IV
- 284.6%
- B/E move
- 29.7%
- Pseudo strike
- 14.16
- IV
- 218.2%
- B/E move
- 14.4%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 14.79
- IV
- 182.5%
- B/E move
- 10.3%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 62.37% | |
| 60.33% | |
| 60.57% | |
| 60.04% | |
| 59.07% |
Drug Manufacturers - Specialty & Generic
RGC
Regal Entertainment Group, is a film exhibitor in the United States. The company is headquartered in Knoxville, Tennessee.
More →SCYX
SCYNEXIS, Inc., a biotechnology company, offers therapies for the treatment of yeast infections in the United States. The company is headquartered in Jersey City, New Jersey.
More →SIGA
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States. The company is headquartered…
More →SUPN
Description unavailable
More →TAK
Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer…
More →TEVA
Description unavailable
More →